Strength of hypoxic vasoconstriction determines shunt fraction in dogs with atelectasis.
We investigated the degree to which strength of pulmonary hypoxic vasoconstriction affects perfusion of pulmonary shunt pathways in acute atelectasis. In 17 intact supine dogs (anesthetized, paralyzed, and ventilated) we produced left lower lobe atelectasis by occluding the lobar bronchus during oxygen inhalation. Subsequently, shunt fraction (reflecting perfusion of that lobe) was measured using an SF6 infusion while the dogs breathed room air; the mean was 26% (range 14-40%). Pulmonary pressor response to hypoxia was assessed in 13 dogs using the increase in pulmonary end-diastolic gradient (PDG) produced by inhalation of 10% oxygen. Those animals with the largest increase in pulmonary diastolic gradient had the smallest shunt fraction while breathing room air, whereas those with the smallest response had the largest shunt fraction. The contribution of local hypoxia to vasoconstriction in the shunt pathway was assessed in 13 dogs breathing room air by measuring the increase in shunt fraction produced by infusing prostaglandin E1 (PGE1). Those with the largest increase in shunt fraction had the smallest pre-PGE1 shunt fraction. Thus the strength of pulmonary vascular reactivity to hypoxia markedly influences the degree of vasoconstriction in shunt pathways and is a major determinant of shunt pathway perfusion.
D000208:Acute Disease; D000527:Alprostadil; D000818:Animals; D001794:Blood Pressure; D004285:Dogs; D000860:Hypoxia / Q000503:physiopathology*; D008168:Lung / Q000502:physiology; D010100:Oxygen / Q000502:physiology; D011458:Prostaglandins E / Q000494:pharmacology; D001261:Pulmonary Atelectasis / Q000503:physiopathology*; D011652:Pulmonary Circulation / Q000187:drug effects; D012119:Respiration; D014661:Vasoconstriction
D011458:Prostaglandins E; D000527:Alprostadil; D010100:Oxygen